Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
Aug 12, 2011
PDF 9.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
Aug 9, 2011
PDF 19.0 KB Add to Briefcase
View Summary Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
Aug 9, 2011
PDF 16.2 KB Add to Briefcase
View Summary Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
Aug 2, 2011
PDF 14.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
Aug 1, 2011
PDF 9.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
Jul 12, 2011
PDF 10.6 KB Add to Briefcase
View Summary Lorcaserin Data to be Presented at the American Diabetes Association's 71st Scientific Sessions
Jun 20, 2011
PDF 14.6 KB Add to Briefcase
View Summary Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals' Lorcaserin Achieved Statistically Significant Weight Loss
May 26, 2011
PDF 13.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals' Lorcaserin to be Featured in Presentations at 18th European Congress on Obesity
May 20, 2011
PDF 11.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
May 10, 2011
PDF 21.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
May 6, 2011
PDF 9.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
May 4, 2011
PDF 10.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces $35.5 Million Financing
Mar 29, 2011
PDF 7.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
Mar 11, 2011
PDF 20.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
Mar 10, 2011
PDF 12.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
Mar 8, 2011
PDF 9.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
Feb 10, 2011
PDF 10.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference
Feb 9, 2011
PDF 9.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Workforce Reduction and Provides Lorcaserin Regulatory Update
Jan 27, 2011
PDF 15.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Jan 6, 2011
PDF 9.0 KB Add to Briefcase
Showing 81-100 of 441 Page: 1 2 3 4 5 6 7 8 9 ... 23  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase